Bicycle Therapeutics' IPO

Bicycle Therapeutics raised a round of funding on May 23, 2019. Investors include Public.

Bicycle Therapeutics (Nasdaq: BCYC) is a clinical-stage biopharmaceutical company developing a class of medicines referred to as Bicycles, for diseases that are underserved by existing therapeutics. B…

Articles about Bicycle Therapeutics' IPO: